The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
about
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
The brain-penetrant clinical A ...... reclinical brain tumor models.
@en
The brain-penetrant clinical A ...... reclinical brain tumor models.
@nl
type
label
The brain-penetrant clinical A ...... reclinical brain tumor models.
@en
The brain-penetrant clinical A ...... reclinical brain tumor models.
@nl
prefLabel
The brain-penetrant clinical A ...... reclinical brain tumor models.
@en
The brain-penetrant clinical A ...... reclinical brain tumor models.
@nl
P2093
P2860
P50
P356
P1433
P1476
The brain-penetrant clinical A ...... preclinical brain tumor models
@en
P2093
Aaron Smith
Akihiro Takano
Anna Cronin
Antonio G Trinidad
Gemma Jones
Ian Barrett
Jasmine Allen
Jenna Kahn
Joanne Wilson
Jonathan Orme
P2860
P304
P356
10.1126/SCIADV.AAT1719
P50
P577
2018-06-20T00:00:00Z